Reimbursed with a limitationOriginator productATC H01AC07

Sogroya

Sogroya is an originator product from Novo Nordisk Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 290.80 to CHF 799.10 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Novo Nordisk Pharma AG
ATC code
H01AC07
IT group
07.03.10 Hypophysenvorderlappen
Active substances
Somapacitanum
Preparation type
Originator product
On the SL since
01/10/2024
Last price change
01/04/2026
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Sogroya Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inj Lös 5 mg/1.5mlFertpen 1.5 mlCHF 252.31CHF 290.8001/10/2024A7680690630010
Inj Lös 10 mg/1.5mlFertpen 1.5 mlCHF 504.62CHF 565.2001/10/2024A7680690630027
Inj Lös 15 mg/1.5mlFertpen 1.5 mlCHF 719.69CHF 799.1001/10/2024A7680690630034

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/10/2024

SOGROYA wird vergütet für die Substitution des endogenen Wachstumshormons (Growth Hormone, GH) bei pädiatrischen Patienten ab dem Alter von 3 Jahren mit Wachstumsstörungen aufgrund eines nachgewiesenen Wachstumshormonmangels (Growth Hormone Deficiency, GHD). Andere Ursachen der Wachstumsstörung müssen ausgeschlossen sein.

FAQ

Is Sogroya covered by Swiss health insurance?

Yes, but only under conditions. Sogroya is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Sogroya cost in Switzerland?

The public price is the maximum price set by the FOPH and for Sogroya ranges from CHF 290.80 to CHF 799.10 per pack. The ex-factory price ranges from CHF 252.31 to CHF 719.69. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com